©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessMyotonia congenita, differential diagnosis

Summary

Short information

A comprehensive panel for Myotonia congenita, differential diagnosis, containing 2 core genes as well as 7 additional genes, almost all of which are also guideline-curated.

ID
MP7030
Number of genes
9 Accredited laboratory test
Examined sequence length
16,3 kb (Core-/Core-canditate-Genes)
17,5 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ATP2A13006NM_173201.5AR
CAV3456NM_033337.3AD
CLCN12967NM_000083.3AD, AR
CNBP534NM_003418.5AD
DMPK1920NM_001081563.2AD
HINT1381NM_005340.7AR
KCNA11488NM_000217.3AD
SCN4A5511NM_000334.4AD
CAVIN11173NM_012232.6AR

Informations about the disease

Clinical Comment

Non-dystrophic myotonias are rare muscle hyperexcitability disorders caused by gain-of-function mutations in the SCN4A gene or loss-of-function mutations in the CLCN1 gene. Myotonia congenita affects skeletal muscles beginning in childhood with bouts of sustained myotonia of any muscles, including of the face and tongue, but most often in the legs causing stiffness sometimes with warm-up effect. The two major types are designated Thomsen disease and Becker disease as distinguished by the severity of symptoms and patterns of inheritance. Becker disease usually appears later in childhood causing more severe stiffness. Becker disease patients often experience temporary attacks of muscle weakness, sometimes permanent over time. Mutations in the CLCN1 gene alter structure and/or function of chloride channels. Thomsen disease is transmitted in an autosomal dominant pattern, Becker disease is inherited in an autosomal recessive manner. The phenotypic manifestations of the pathogenic variants in the CLCN1 and SCN4A genes can be variable even within the same family; many autosomal dominant pathogenic variants can be associated with reduced penetrance. Both, the analytical sensitivity and specificity are close to 100%, the clinical sensitivity and specificity are dependent on variable factors such as age and/or family history.

Reference:

Reference: https://www.ncbi.nlm.nih.gov/books/NBK1355/

 

Synonyms
  • Alias: Non-dystrophic skeletal muscle disorder
  • Alias: Thomsen + Becker disease
  • Allelic: Cardiomyopathy, familial hypertrophic (CAV3)
  • Allelic: Creatine phosphokinase, elevated serum (CAV3)
  • Allelic: Long QT syndrome 9 (CAV3)
  • Brody myopathy (ATP2A1)
  • Episodic ataxia/myokymia syndrome (KCNA1)
  • Hyperkalemic periodic paralysis, type 2 (SCN4A)
  • Hypokalemic periodic paralysis, type 2 (SCN4A)
  • Lipodystrophy, congenital generalized, type 4 (CAVIN1)
  • Myasthenic syndrome, congenital, 16 (SCN4A)
  • Myopathy, distal, Tateyama type (CAV3)
  • Myotonia congenita, AD (CLCN1)
  • Myotonia congenita, AR (CLCN1)
  • Myotonia congenita, atypical, acetazolamide-responsive (SCN4A)
  • Myotonia levior, AR (CLCN1)
  • Myotonic dystrophy 1 (DMPK)
  • Myotonic dystrophy 2 (CNBP)
  • Neuromyotonia + axonal neuropathy, AR (HINT1)
  • Paramyotonia congenita (SCN4A)
  • Rippling muscle disease 2 (CAV3)
Heredity, heredity patterns etc.
  • AD
  • AR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined